Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of zoledronic acid on breast cancer
IRCT20250513065707N1Phase 3Completed
- Sponsor
- Kashan University of Medical Sciences
- Start
- May 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of zoledronic acid in breast cancer, sponsored by Kashan University of Medical Sciences. Started May 2025; status: completed.
02
Drugs
zoledronic acid
03
Conditions
breast cancer
Beyond the preview
Go deeper on IRCT20250513065707N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20250513065707N1.